Controversies: molecular vs. clinical systemic sclerosis classification
Johnson S, Hinchcliff M, Asano Y. Controversies: molecular vs. clinical systemic sclerosis classification. Journal Of Scleroderma And Related Disorders 2016, 1: 277-285. DOI: 10.5301/jsrd.5000213.Peer-Reviewed Original ResearchSystemic sclerosisMolecular classificationClassification of SScAutoimmunity/inflammationDisease-related autoantibodiesPopulation-based studyClinical classification systemDaily clinical practiceCardinal pathological featuresMultisystem chronic diseaseMolecular targeting therapyEstimates of outcomesComplex heterogeneous disorderInternal organ diseaseSkin sclerosisLaboratory featuresSSc patientsClinical presentationPathological featuresUnknown etiologyClassification systemChronic diseasesOrgan diseaseIndividual patientsPotential respondersThe relationship between skin symptoms and the scleroderma modification of the health assessment questionnaire, the modified Rodnan skin score, and skin pathology in patients with systemic sclerosis
Ziemek J, Man A, Hinchcliff M, Varga J, Simms RW, Lafyatis R. The relationship between skin symptoms and the scleroderma modification of the health assessment questionnaire, the modified Rodnan skin score, and skin pathology in patients with systemic sclerosis. Rheumatology 2016, 55: 911-917. PMID: 26880832, PMCID: PMC5854039, DOI: 10.1093/rheumatology/kew003.Peer-Reviewed Original ResearchConceptsRodnan skin scoreHealth Assessment QuestionnaireSkin symptomsSkindex-29Skin scoreAssessment QuestionnaireSkin diseasesSkin pathologySSc skin diseaseSymptom assessment questionnairePatient's skin symptomsSSc patientsSystemic sclerosisAtopic dermatitisPathological featuresSymptom assessmentPhysical examMyofibroblast infiltrationPathological changesPathological measuresPatientsSymptom instrumentsSymptomsDiseaseSHAQ